• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vækstaktier.dk: Scandinavian Medical Solutions strengthens long-standing partnership in Central Asia with new million-kroner sale

SMSMEDPress release11.08.2026 klo 17.00

Scandinavian Medical Solutions has sold a GE Signa Artist 1.5T MRI scanner to one of its key partners in Central Asia.

The deal is the latest in a long series of sales to the same customer, with whom Scandinavian Medical Solutions has maintained a close partnership for several years, and which has continuously expanded its scanning capacity through purchases from the company.

The repeat sale to the same customer reflects the trust key partners place in SMS' ability to deliver operational and reliable equipment across recurring transactions. GE's Signa Artist platform is a versatile 1.5T system known for its patient-friendly design and broad clinical applicability. This makes the system a popular choice for hospitals and clinics that require stable scanning capacity across multiple departments.

Demand for accessible 1.5T systems such as the Signa Artist reflects a broader trend in the region, where investment in diagnostic imaging is increasing as healthcare infrastructure and clinical capacity are expanded. The combination of price, operational reliability, and broad clinical applicability makes the 1.5T segment a central component of many hospitals' and clinics' overall scanning capacity.

For Scandinavian Medical Solutions, the deal underscores the importance of long-term customer relationships in Central Asia, where repeat business with existing customers constitutes a central element of the company's activities in the region. The sale is in line with SMS' strategy of both maintaining and expanding cooperation with existing customers as well as establishing new relationships in the market.

The sale is announced in accordance with the company's communication policy, and the order falls within the range of DKK 2.0-3.5 million. Following the announcement of three orders in August, Scandinavian Medical Solutions has now announced orders totaling DKK 38-61 million in the current financial year.

About Us
Disclaimer: Vaekstaktier has a paid IR-partnership with the company mentioned. The content is for informational purposes and is a redistribution of the company’s own communications.

Website: vaekstaktier.dk

Attachments
Scandinavian Medical Solutions strengthens long-standing partnership in Central Asia with new million-kroner sale